Logan Capital Management Inc. Acquires New Position in Revvity, Inc. (NYSE:RVTY)

Logan Capital Management Inc. acquired a new stake in Revvity, Inc. (NYSE:RVTYFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 335 shares of the company’s stock, valued at approximately $37,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Parkside Financial Bank & Trust acquired a new position in Revvity in the 4th quarter worth approximately $25,000. Gladius Capital Management LP increased its holdings in Revvity by 84.1% in the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after buying an additional 106 shares during the period. CENTRAL TRUST Co acquired a new position in Revvity in the 4th quarter worth approximately $27,000. Benjamin F. Edwards & Company Inc. acquired a new position in Revvity in the 4th quarter worth approximately $27,000. Finally, ORG Partners LLC acquired a new position in Revvity in the 4th quarter worth approximately $32,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Stock Down 1.5 %

NYSE RVTY opened at $109.30 on Tuesday. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $131.96. The company has a quick ratio of 1.92, a current ratio of 2.23 and a debt-to-equity ratio of 0.40. The business’s fifty day simple moving average is $106.03 and its 200-day simple moving average is $104.69. The firm has a market cap of $13.49 billion, a PE ratio of 90.33, a P/E/G ratio of 2.89 and a beta of 1.08.

Revvity (NYSE:RVTYGet Free Report) last issued its quarterly earnings data on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.04. The firm had revenue of $649.90 million during the quarter, compared to the consensus estimate of $646.83 million. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The company’s quarterly revenue was down 3.7% on a year-over-year basis. During the same period last year, the company earned $1.01 EPS. As a group, equities analysts anticipate that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Shareholders of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. Revvity’s dividend payout ratio (DPR) is presently 23.14%.

Insiders Place Their Bets

In other Revvity news, insider Joel S. Goldberg sold 4,000 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $110.46, for a total transaction of $441,840.00. Following the sale, the insider now directly owns 36,900 shares in the company, valued at $4,075,974. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Robert W. Baird raised their price objective on shares of Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. Jefferies Financial Group assumed coverage on shares of Revvity in a research note on Monday, June 3rd. They set a “hold” rating and a $115.00 price objective on the stock. Finally, TD Cowen raised their price objective on shares of Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, April 30th. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Revvity currently has an average rating of “Moderate Buy” and a consensus target price of $117.92.

Get Our Latest Stock Report on RVTY

Revvity Company Profile

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Stories

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.